摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-tert-Butoxycarbonylamino-5,5-difluoro-2-hydroxy-pentanoic acid | 669063-39-2

中文名称
——
中文别名
——
英文名称
3-tert-Butoxycarbonylamino-5,5-difluoro-2-hydroxy-pentanoic acid
英文别名
——
3-tert-Butoxycarbonylamino-5,5-difluoro-2-hydroxy-pentanoic acid化学式
CAS
669063-39-2
化学式
C10H17F2NO5
mdl
——
分子量
269.245
InChiKey
IVMNWZKDYZFQOR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    3-tert-Butoxycarbonylamino-5,5-difluoro-2-hydroxy-pentanoic acid 在 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 作用下, 生成 3-Amino-5,5-difluoro-2-hydroxy-pentanoic acid ((S)-1-phenyl-ethyl)-amide; compound with trifluoro-acetic acid
    参考文献:
    名称:
    P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors
    摘要:
    With the aim of discovering potent and selective HCV protease inhibitors, we synthesized and evaluated a series of Ia based tetrapeptidyl ketoamides with additional modification(s) at P1', P1, and P3 positions. As a result of this effort, we found that replacement of the P3 valine with tert-leucine resulted in the discovery of a series of inhibitors (e.g., 3a, 3c, and 4c) endowed with improved enzyme and/or cellular activity relative to Ia. When dosed to F-344 rats orally at 50 mg/kg, 3a achieved 2.5 x higher liver and plasma exposure in comparison to that detected with 1a. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.09.075
  • 作为产物:
    描述:
    [2-Cyano-1-(2,2-difluoro-ethyl)-2-hydroxy-ethyl]-carbamic acid tert-butyl ester 在 盐酸 作用下, 以 1,4-二氧六环 为溶剂, 生成 3-tert-Butoxycarbonylamino-5,5-difluoro-2-hydroxy-pentanoic acid
    参考文献:
    名称:
    A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease
    摘要:
    The difluoromethyl group was designed by computational chemistry methods as a mimetic of the canonical P-1 cysteine thiol for inhibitors of the hepatitis C virus NS3 protease. This modification led to the development of competitive, non-covalent inhibitor 4 (K-i 30 nM) and reversible covalent inhibitors (6, K-i 0.5 nM; and 8 K-i* 10 pM). (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00842-3
点击查看最新优质反应信息

文献信息

  • Inhibitors of hepatitis C virus NS3/4A: α-Ketoamide based macrocyclic inhibitors
    作者:Salvatore Avolio、Keith Robertson、Josè Ignacio Martin Hernando、Jillian DiMuzio、Vincenzo Summa
    DOI:10.1016/j.bmcl.2009.02.079
    日期:2009.4
    A novel series of hepatitis C virus (HCV) NS3/4A protease inhibitors bearing a P2-P4 macrocycle and a P1-P1' alpha-ketoamide serine trap is reported. The NS3 protease, which is essential for viral replication, is considered one of the most attractive targets for developing novel anti-HCV therapies. The optimization of both the macrocycle and the warhead portions led to the discovery of compounds 8b and 8g with a good activity both in the enzyme as well as in the cell based (replicon) assays with favorable PK profile in a preclinical species. (c) 2009 Elsevier Ltd. All rights reserved.
查看更多